{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-005384","form_type":"8-K","ticker":"NTRA","cik":"0001604821","company_name":"Natera, Inc.","filed_at":"2024-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.786060+00:00","generated_at":"2026-06-06T20:40:28.939754+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Natera acquires Invitae's prenatal and carrier screening assets for $10M upfront","bullets":["Upfront cash payment of $10 million to Invitae for reproductive health assets.","Additional potential milestone payments of $42.5 million, including cash and litigation-related credits.","Invitae will transition its non-invasive prenatal screening and carrier screening customers to Natera.","Acquisition expands Natera's cfDNA testing reach; CEO Steve Chapman cites commitment to service."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-005384","json":"https://secwatch.observer/filing/0001104659-24-005384.json","markdown":"https://secwatch.observer/filing/0001104659-24-005384.md","text":"https://secwatch.observer/filing/0001104659-24-005384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604821/000110465924005384/0001104659-24-005384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604821/000110465924005384/tm243767d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T20:40:28.939754+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}